Pulike Biological Engineering (SHSE:603566) FCF Margin %: -18.77% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603566 Pulike Biological Engineering Inc SHSE:603566
64 GF Score
Price ¥10.31
GF Value ¥14.30
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Pulike Biological Engineering FCF Margin %?

Pulike Biological Engineering SHSE:603566 -2.00% 64 FCF Margin % is -18.77% as of Mar. 2026. GuruFocus rates SHSE:603566 with a GF Score™ of 64/100 and a GF Value™ of ¥14.30 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 950 Biotechnology companies, Pulike Biological Engineering ranks better than 88.53% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Pulike Biological Engineering's Free Cash Flow for the three months ended in Mar. 2026 was ¥-47 Mil. Pulike Biological Engineering's Revenue for the three months ended in Mar. 2026 was ¥249 Mil. Therefore, Pulike Biological Engineering's FCF Margin % for the quarter that ended in Mar. 2026 was -18.77%.

As of today, Pulike Biological Engineering's current FCF Yield % is 5.62%.

The historical rank and industry rank for Pulike Biological Engineering's FCF Margin % or its related term are showing as below:

SHSE:603566' s FCF Margin % Range Over the Past 10 Years
Min: -10.47   Med: 10.54   Max: 30.74
Current: 18.89

During the past 13 years, the highest FCF Margin % of Pulike Biological Engineering was 30.74%. The lowest was -10.47%. And the median was 10.54%.

SHSE:603566's FCF Margin % is ranked better than
88.53% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs SHSE:603566: 18.89

Pulike Biological Engineering FCF Margin % Related Terms

Pulike Biological Engineering FCF Margin % Historical Data

* Premium members only.

The historical data trend for Pulike Biological Engineering's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulike Biological Engineering FCF Margin % Chart

Pulike Biological Engineering Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.56 -10.47 -1.77 14.17 25.81

Pulike Biological Engineering Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.26 46.61 25.41 18.46 -18.77

SHSE:603566 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Pulike Biological Engineering's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pulike Biological Engineering FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pulike Biological Engineering's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Pulike Biological Engineering's FCF Margin % falls into.


SHSE:603566
64GF Score
Pulike Biological Engineering Inc SHSE:603566
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pulike Biological Engineering FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Pulike Biological Engineering's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=281.301/1089.878
=25.81 %

Pulike Biological Engineering's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-46.777/249.24
=-18.77 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -18.77% mean?
Pulike Biological Engineering (SHSE:603566) has a FCF Margin % of -18.77% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pulike Biological Engineering and its competitors. According to the industry distribution chart, Pulike Biological Engineering ranks #109 out of 950 companies in the Biotechnology industry, placing it in the top 11.5%.
Is Pulike Biological Engineering's FCF Margin % too high?
Pulike Biological Engineering's current FCF Margin % is -18.77%. Based on the distribution chart, Pulike Biological Engineering ranks #109 out of 950 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Pulike Biological Engineering has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pulike Biological Engineering's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pulike Biological Engineering ranks #109 out of 950 companies for FCF Margin %. This places Pulike Biological Engineering in the top 12% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Pulike Biological Engineering and its competitors. Pulike Biological Engineering's current FCF Margin % is -18.77%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulike Biological Engineering stock overvalued right now?
Based on GuruFocus' analysis, Pulike Biological Engineering (SHSE:603566) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.30, compared to a current price of ¥10.31 — trading 27.9% below its estimated fair value. The current FCF Margin % is -18.77%. Pulike Biological Engineering's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Pulike Biological Engineering (SHSE:603566), the current FCF Margin % is -18.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pulike Biological Engineering (SHSE:603566) Overvalued in 2026?

Based on GuruFocus' analysis, Pulike Biological Engineering stock appears to be undervalued. The current stock price of ¥10.31 is trading 27.9% below its estimated GF Value™ of ¥14.30. GuruFocus considers Pulike Biological Engineering to be Modestly Undervalued.

Key valuation signals for SHSE:603566:

  • FCF Margin %: -18.77%
  • GF Value™: ¥14.30 vs. price of ¥10.31 (27.9% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pulike Biological Engineering Business Description

Address 15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
64GF Score

Get the complete analysis for SHSE:603566

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥10.31
Price
¥14.30
GF Value